Caxton Associates (UK)’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,535
Closed -$1.36M 902
2026
Q1
$1.36M Buy
+11,535
New +$1.51M 0.03% 306
2025
Q4
Sell
-9,456
Closed -$947K 912
2025
Q3
$947K Buy
9,456
+1,508
+19% +$180K 0.02% 348
2025
Q2
$1.02M Buy
+7,948
New +$967K 0.03% 318

Other funds holding NOVT

Caxton Associates (UK)'s NOVT Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Novanta (NOVT) in Q2 2026, closing a stake of 11,535 shares — an estimated $1.36M sold.

Caxton Associates (UK) first reported a position in NOVT in Q2 2025 and held it in 3 quarters. The position peaked at $1.36M in Q1 2026. 390 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Novanta position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 11,535 Novanta shares in Q2 2026, an estimated $1.36M.
  • Caxton Associates (UK) first reported a position in Novanta in Q2 2025 and held it in 3 quarters.
  • Caxton Associates (UK)'s Novanta position peaked at $1.36M in Q1 2026.
  • 390 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.